Purpose: This paper aims to detect how intangibles can create scalable, synergistic and externally perceived value, softening debt constraints that traditionally affect IC.Design/Methodology/Approach: A comprehensive IC valuation approach is theoretically linked to measurable accounting sources,...

Financial technology (FinTech) is an industry composed of diversified companies that use technology to make financial services more efficient. Fintech is recognized as one of the most critical innovations in the financial industry and is evolving at a rapid speed, driven in part by the sharing...

The economic valuation of goodwill is based on an interdisciplinary approach that synergistically considers the legal, accounting, fiscal, and strategic aspects. The controversial concept of goodwill (goodwill if positive, badwill if negative) has always divided lawyers, businesspeople, and...

An intangible is a non-monetary asset that manifests itself by its economic properties. It does not have physical substance but grants rights and economic benefits to its owner. The examination of the general approaches of valuation of companies is preliminary to the estimation of assets such as...

Chapter 1: Introduction -- PART 1: VALUATION PRINCIPLES -- Chapter 2: General principles of valuation -- Chapter 3: The valuation of intangible assets: an introduction -- Chapter 4: Goodwill valuation -- Chapter 5: Augmented Business Modeling and Planning as a Prerequisite for Valuation --...

The know-how expresses the concept of "know-how", straddling the organization in series and technology, legally protected as an industrial secret. The sharing and transferability of know-how is the basis of its economic appraisal, which is based on complementary methodologies projecting the...

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, intending to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...